Mackenzie Financial’s Ascendis Pharma A/S ASND Stock Holding History

Mackenzie Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$685K	Buy	+2,569	New	+$600K	﹤0.01%	1257
2024 Q3	–	Sell	-5,319	Closed	-$725K	–	1582
2024 Q2	$725K	Sell	5,319 -208	-4%	-$28.3K	﹤0.01%	926
2024 Q1	$836K	Buy	5,527 +1,072	+24%	+$153K	﹤0.01%	919
2023 Q4	$561K	Sell	4,455 -198	-4%	-$19.7K	﹤0.01%	968
2023 Q3	$409K	Sell	4,653 -353	-7%	-$33K	﹤0.01%	1051
2023 Q2	$441K	Sell	5,006 -939	-16%	-$81.7K	﹤0.01%	1055
2023 Q1	$637K	Sell	5,945 -467	-7%	-$53.4K	﹤0.01%	955
2022 Q4	$783K	Buy	6,412 +733	+13%	+$85.1K	﹤0.01%	812
2022 Q3	$586K	Buy	5,679 +1,384	+32%	+$131K	﹤0.01%	898
2022 Q2	$399K	Buy	4,295 +1,393	+48%	+$131K	﹤0.01%	991
2022 Q1	$341K	Sell	2,902 -5,124	-64%	-$593K	﹤0.01%	1070
2021 Q4	$1.08M	Sell	8,026 -509	-6%	-$75.7K	﹤0.01%	894
2021 Q3	$1.36M	Sell	8,535 -455	-5%	-$62.3K	﹤0.01%	837
2021 Q2	$1.18M	Sell	8,990 -670	-7%	-$89.3K	﹤0.01%	828
2021 Q1	$1.25M	Buy	9,660 +610	+7%	+$92.7K	﹤0.01%	779
2020 Q4	$1.51M	Buy	9,050 +438	+5%	+$72.4K	﹤0.01%	656
2020 Q3	$1.33M	Buy	8,612 +783	+10%	+$113K	﹤0.01%	626
2020 Q2	$1.16M	Sell	7,829 -224	-3%	-$30.8K	﹤0.01%	651
2020 Q1	$907K	Sell	8,053 -249	-3%	-$32.4K	﹤0.01%	667
2019 Q4	$1.16M	Sell	8,302 -520	-6%	-$57.8K	﹤0.01%	708
2019 Q3	$850K	Buy	8,822 +1,253	+17%	+$140K	﹤0.01%	745
2019 Q2	$872K	Buy	+7,569	New	+$906K	﹤0.01%	771

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mackenzie Financial's ASND Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 2,569 shares worth $685K. The stake represents ﹤0.01% of the portfolio and ranks #1257 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in ASND as recently as Q2 2024.

Mackenzie Financial first reported a position in ASND in Q2 2019 and has held it in 22 quarters since. The position peaked at $1.51M in Q4 2020. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Mackenzie Financial held 2,569 shares of Ascendis Pharma A/S worth $685K as of Q2 2026.
Ascendis Pharma A/S was a new Mackenzie Financial position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1257 holding.
Mackenzie Financial first reported a position in Ascendis Pharma A/S in Q2 2019 and has held it in 22 quarters since.
Mackenzie Financial's Ascendis Pharma A/S position peaked at $1.51M in Q4 2020.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.